Description | Nervegrowthfactor(NGF)receptor,alsoknownasp75NTR,isalowaffinityNGFreceptor.ItbindswithequalaffinityallmembersoftheneurotrophinfamilyincludingbetaNGF,BDNF,NT-3andNT-4/5.Italsobindsthepro-neurotrophins.NGFreceptorsmediatesignalingofneurotrophinsforneuronalsurvival,apoptosis,neuriteoutgrowthandsynapticplasticity.ThesereceptorsarealsothoughttoplayaroleinneurogenerativediseasessuchasAlzheimersdisease.Thep75NTRNGFreceptorisatypeItransmembraneglycoprotein(396aa)consistingofasignalpeptide(21aa),anextracellulardomain(225aa)whichcontainsfourcysteinerichdomainsresponsIBLeforligandbinding,atransmembranedomain(19aa)andacytoplasmicdomain(152aa).ItisamemberoftheTNF-alphareceptorfamily(TNR16).Recently,p75NTRhasbeenshowntoactasareceptorformanypathogenssuchasprions,rABIesvirusandamyloidbeta.Italsoactsasaco-receptorforNOGO,mediatinginhibitorysignalsofmyelinassociatedprotein. |
BatchNo. | Seeproductlabel |
Unitsize | 25µg |
OtherNames | Low-affinitynervegrowthfactorreceptor;NGFreceptor;Gp80-LNGFR;p75ICD;Lowaffinityneurotrophinreceptorp75NTR;p75NTR;CD271;FastNGFreceptor. |
Accession | Q9Z0W1TNR16_MOUSE; |
Producedin | Mammalian(CHO)cells.ADNAsequenceencodingthesignalpeptideandextracellulardomainofhumanNGFreceptor(aminoacids1-224)wasfusedtotheFcregionofhumanIgG1(aminoacids104-330).ThechimericproteinwasexpressedinmodifiedCHOcells.Thefullsequenceisavailableonrequestfrombiospeak@Biosensis.com. |
MolecularWeight | TheNGFReceptor-Fcchimeramigratesasabroadbandbetween65and115kDainSDS-PAGEduetopost-translationalmodifications,inparticularglycosylation.TheunmodifiedNGFReceptor-Fcchimerahasapredictedmassof49.7kDa.TheunmodifiedNGFReceptor-FcchimerahasapredictedpIof4.92. |
Purity | >95%,asdeterminedbySDS-PAGE. |
Form | Freeze-dried. |
Reconstitution | Itisrecommendedthat0.25mlofsterilephosphate-bufferedsaline(PBS)beaddedtothevial. |
Storage | Lyophilizedproductsshouldbestoredat2-8°C.Followingreconstitution,short-termstorageat4°Cisrecommendedandlonger-termstorageofaliquotsat-18to-20°C.Repeatedfreezethawingisnotrecommended. |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。